Background illustration for clinical trials search

Pancreatic Cancer Clinical Trials

Browse 1,722 pancreatic cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Study of Herbal Supplements in Cancer Survivors With Constipation

for
Constipation, Cancer, Functional Constipation
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07091084

Recruiting

A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

for
Solid Cancer
Location: New Haven CT, Lake Success NY, New York NY, Teaneck NJ,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06161025

Phase 2, Phase 3, Recruiting

Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors

for
Cancer, Survivorship
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT07454330

Recruiting

Support for Bereaved Cancer Caregivers

for
Bereavement, Cancer, Caregiver, Grief
Location: East Lansing MI
Sponsor: Michigan State University

Sex: All

Age: 18+

Code: NCT06662409

Recruiting

Evaluating Informatics-assisted Immune-related Adverse Event Detection to Improve Registration Onto a Biorepository

for
Malignancy, Immune Related Adverse Events
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 0+

Code: NCT06789601

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: Hackensack NJ, Fairfax VA, Madison WI, Houston TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06598800

Phase 1, Recruiting

Patient Interest in an Integrative Oncology Program at USC Norris Cancer Center: A Single-Institution Needs Assessment

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 18+

Code: NCT07306338

Recruiting

Development and Pilot Trial of Focused ACT (FACT) for Patients With Advanced Cancer

for
Advanced Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07105033

Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Boston MA, New York NY, Philadelphia PA,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase 2, Phase 3, Recruiting

Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours

for
Solid Tumours
Location: Providence RI, New York NY, Fairfax VA, Houston TX
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT07446855

Phase 1, Phase 2, Recruiting

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

for
Advanced Solid Tumor, Advanced Breast Cancer,
Location: Lebanon NH, New Hyde Park NY, New York NY, Buffalo NY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT06997029

Phase 1, Recruiting

Study of AUBE00 in Patients With Solid Tumors

for
Solid Tumors
Location: Fairfax VA, Grand Rapids MI, Houston TX
Sponsor: Chugai Pharmaceutical

Sex: All

Age: 18+

Code: NCT07030959

Phase 1, Recruiting

A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials

for
Cancer
Location: Jacksonville FL
Sponsor: University of Florida

Sex: All

Age: 18 - 70+

Code: NCT05655494

Recruiting

Telephone-Based Coaching Sessions (TAC) to Improve Advance Care Planning Participation in Advanced Cancer Patients and Their Support Person

for
Advanced Malignant Solid Neoplasm,
Location: Mount Vernon WA, Everett WA, Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07141407

Recruiting

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

for
Locally Advanced/Metastatic Solid Tumors
Location: New Haven CT, Indianapolis IN, Nashville TN, Denver CO,
Sponsor: InSilico Medicine Hong Kong Limited

Sex: All

Age: 18+

Code: NCT06414460

Phase 1, Phase 2, Recruiting

Exercise and Cognitive Rehab in Older Cancer Survivors

for
Cancer
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT05388214

Recruiting

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT07517198

Phase 1, Recruiting

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center

Sex: All

Age: 15 - 39

Code: NCT06941324

Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

for
Solid Tumors
Location: New York NY, Philadelphia PA, Norfolk VA, Fairfax VA,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06885281

Phase 1, Phase 2, Recruiting

A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors

for
Advanced Solid Tumors
Location: Fairfax VA, Scottsdale AZ
Sponsor: Samsung Bioepis Co., Ltd.

Sex: All

Age: 18+

Code: NCT07524348

Phase 1, Recruiting

What is pancreatic cancer?

The pancreas sits deep behind the stomach and makes both digestive enzymes and hormones like insulin. About 92 percent of pancreatic cancers start in the enzyme making cells, and this page is mostly about those. The other 8 percent are neuroendocrine tumors, which grow more slowly, have their own trials, and a five year survival of 72 percent against 8 percent. The pancreas gives no early warning. Jaundice, back pain, weight loss and new diabetes usually appear only after the cancer has grown or spread, and fewer than 20 percent of people can have surgery at diagnosis.

Smoking roughly doubles the risk, and type 2 diabetes, extra weight, chronic pancreatitis and family history raise it. About 10 percent of cases come from inherited mutations, so guidelines now recommend genetic testing for everyone diagnosed. That can change treatment and flag relatives who should be watched. The hope comes from biology. More than 90 percent of pancreatic cancers carry a KRAS mutation. That target was called undruggable for decades. Now several RAS inhibitors are in trials, with the first Phase 3 studies recruiting. Pancreatic cancer shares risk factors with type 2 diabetes and inherited genes with breast and ovarian cancer.

Article preview image

Our guide to new treatments for pancreatic cancer covers what has been approved and what is being tested.

Research Paving The Way To A New Treatment For Pancreatic Cancer

Types of pancreatic cancer clinical trials

Who can participate in pancreatic cancer clinical trials?

What causes pancreatic cancer?

The stages of pancreatic cancer, and why they matter for trials

How to enroll in a pancreatic cancer clinical trial